TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE AURORA KINASE A INHIBITOR LY3295668

被引：0
|
作者：
Mehta, Shwetal [1 ]
Tovmasyan, Artak [1 ]
Tien, An-Chi [1 ]
Holter, Michael [1 ]
Hopkins, Barbara [1 ]
Margaryan, Tigran [1 ]
Chang, Yu-Wei [1 ]
Himes, Sarah [1 ]
Elliott, Mackenna [1 ]
Melendez, Ernesto Luna [1 ]
Pennington-Krygier, Chelsea [1 ]
White, Connor [1 ]
Molloy, Jennifer [1 ]
Liu, Miao [1 ]
Knight, William [1 ]
Sanai, Nader [1 ]
机构：
[1] Barrow Neurol Inst, Ivy Brain Tumor Ctr, Phoenix, AZ 85013 USA
来源：
NEURO-ONCOLOGY | 2021年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
EXTH-09
引用
收藏
页码：165 / 165
页数：1
相关论文
共 44 条
  • [1] TUMOR PHARMACOKINETICS, PHARMACODYNAMICS AND RADIATION SENSITIZATION IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE SECOND-GENERATION HDAC INHIBITOR, QUISINOSTAT
    Lo Cascio, Costanza
    Margaryan, Tigran
    Melendez, Ernesto Luna
    McNamara, James
    Knight, William
    Himes, Sarah
    Sanai, Nader
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2021, 23 : 168 - 168
  • [2] TUMOR PHARMACOKINETICS AND PHARMACODYNAMICS IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA TREATED WITH THE PRMT5 INHIBITOR SKL27969
    Tien, An-Chi
    Margaryan, Tigran
    Molloy, Jennifer
    McNamara, James
    Knight, William
    Hon, Raymond
    Opachich, Zorana
    Melendez, Ernesto Luna
    Elliott, Mackenna
    White, Connor
    Sanai, Nader
    Tovmasyan, Artak
    Mehta, Shwetal
    NEURO-ONCOLOGY, 2023, 25
  • [3] Tumor pharmacokinetics and pharmacodynamics assessment of TEAD inhibitor VT03989 in patient-derived xenograft models of glioblastoma
    Margaryan, Tigran
    Chang, Yu-Wei
    Molloy, Jennifer
    Hopkins, Barbara
    Elliott, Mackenna
    Melendez, Ernesto Luna
    White, Connor
    Sanai, Nader
    Tien, An-Chi
    Tovmasyan, Artak
    Mehta, Shwetal
    CANCER RESEARCH, 2024, 84 (06)
  • [4] Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
    Randall, Elizabeth C.
    Emdal, Kristina B.
    Laramy, Janice K.
    Kim, Minjee
    Roos, Alison
    Calligaris, David
    Regan, Michael S.
    Gupta, Shiv K.
    Mladek, Ann C.
    Carlson, Brett L.
    Johnson, Aaron J.
    Lu, Fa-Ke
    Xie, X. Sunney
    Joughin, Brian A.
    Reddy, Raven J.
    Peng, Sen
    Abdelmoula, Walid M.
    Jackson, Pamela R.
    Kolluri, Aarti
    Kellersberger, Katherine A.
    Agar, Jeffrey N.
    Lauffenburger, Douglas A.
    Swanson, Kristin R.
    Tran, Nhan L.
    Elmquist, William F.
    White, Forest M.
    Sarkaria, Jann N.
    Agar, Nathalie Y. R.
    NATURE COMMUNICATIONS, 2018, 9
  • [5] Integrated mapping of pharmacokinetics and pharmacodynamics in a patient-derived xenograft model of glioblastoma
    Elizabeth C. Randall
    Kristina B. Emdal
    Janice K. Laramy
    Minjee Kim
    Alison Roos
    David Calligaris
    Michael S. Regan
    Shiv K. Gupta
    Ann C. Mladek
    Brett L. Carlson
    Aaron J. Johnson
    Fa-Ke Lu
    X. Sunney Xie
    Brian A. Joughin
    Raven J. Reddy
    Sen Peng
    Walid M. Abdelmoula
    Pamela R. Jackson
    Aarti Kolluri
    Katherine A. Kellersberger
    Jeffrey N. Agar
    Douglas A. Lauffenburger
    Kristin R. Swanson
    Nhan L. Tran
    William F. Elmquist
    Forest M. White
    Jann N. Sarkaria
    Nathalie Y. R. Agar
    Nature Communications, 9
  • [6] Population pharmacokinetics of an aurora kinase A inhibitor, LY3295668 erbumine (AK-01), in patients with locally advanced or metastatic solid tumors
    Yuen, Eunice
    Hui, Yu-Hua
    de la Pena, Amparo
    Tate, Sonya C.
    Stille, John R.
    Lithio, Andrew
    Smith, Patricia S.
    Chu, Quincy
    Batist, Gerald
    Bouganim, Nathaniel
    Fortier, Caroline
    Zaknoen, Sara
    Kremer, Jill
    CANCER RESEARCH, 2019, 79 (13)
  • [7] CIRCULATING TUMOR DNA ANALYSIS IN PATIENT-DERIVED XENOGRAFT MODELS OF GLIOBLASTOMA
    Perdigones, Nieves
    Connor, Sydney
    Hartman, Lauren
    Contente-Cuomo, Tania
    Reid, George
    Markus, Havell
    Berens, Michael
    Dhruv, Harshil
    Murtaza, Muhammed
    NEURO-ONCOLOGY, 2017, 19 : 101 - 101
  • [8] Tumor pharmacokinetics, pharmacodynamics and efficacy analysis of WEE1 inhibitor, zn-c3 in patient- derived xenograft models of glioblastoma
    Mehta, Shwetal
    Tien, An-Chi
    Patel, Sonam
    Margaryan, Tigran
    Shivanna, Anilkumar Thaghalli
    Elena, Leonel
    Molloy, Jennifer
    Knight, William
    Hon, Ruiheng
    Elliott, Mackenna
    Stavnichuk, Mariya
    Opachich, Zorana
    Chang, Yu-Wei
    Montgomery, Chelsea
    Himes, Sarah
    Hopkins, Barbara
    Tovmasyan, Artak
    Sanai, Nader
    CANCER RESEARCH, 2023, 83 (07)
  • [9] EFFICACY OF THE MDM2 INHIBITOR KRT-232 IN GLIOBLASTOMA PATIENT-DERIVED XENOGRAFT MODELS
    Vaubel, Rachael
    Mladek, Ann
    Zhao, Yu
    Gupta, Shiv K.
    Kim, Minjee
    Mohammad, Afroz S.
    Bakken, Katrina
    He, Lihong
    Hu, Zeng
    Burgenske, Danielle M.
    Carlson, Brett L.
    Elmquist, William F.
    Sarkaria, Jann
    NEURO-ONCOLOGY, 2020, 22 : 231 - 231
  • [10] Anti-tumor effects of dovitinib, a multi-target kinase inhibitor, in patient-derived gastrointestinal stromal tumor (GIST) xenograft models
    Gebreyohannes, Yemarshet Kelemework
    Van Looy, Thomas
    Wozniak, Agnieszka
    Wellens, Jasmien
    Li, Haifu
    Cornillie, Jasmien
    Vanleeuw, Ulla
    Vreys, Lise
    Squires, Matthew
    Rodringuez, Ana-Maria
    Debiec-Rychter, Maria
    Sciot, Raf
    Schoffski, Patrick
    CANCER RESEARCH, 2015, 75
12345